Latest news
AB2 Bio Receives $30 Million From Nippon Shinyaku For U.S. Tadekinig Alfa Rights, With Up To $600 Million In Milestones And Royalties - Pulse 2.0Pulse 2.0 · Mon, 03 Aug 2026 01:58:58 GMTAB2 Bio Gets $30 Mln From Nippon Shinyaku For U.S. Rights To Tadekinig Alfa - TradingViewTradingView · Thu, 30 Jul 2026 06:51:00 GMT